FIELD: chemistry; medicine.
SUBSTANCE: invention refers to chemistry and medicine, namely to pharmaceutical chemistry and pharmacology. Summary: application of L-proline (L-proline acetylsalicylate) or L-tyrosine (L-tyrosine acetylsalicylate) of general formula presented below, as an agent exhibiting antiaggregatory activity. Compounds of the invention exhibit antiaggregatory activity superior to acetylsalicylic acid (see Table 1).
EFFECT: invention can be used for creating new drug preparations for preventing thrombosis and thromboembolic complications.
1 cl, 3 ex, 1 tbl
Title | Year | Author | Number |
---|---|---|---|
DERIVATIVES OF 1-(3,5-DI-TERT-BUTYL-4-HYDROXYBENZYL)ISATIN HAVING ANTIAGGREGATORY ACTIVITY | 2023 |
|
RU2822271C1 |
L-ALANINIUM ACETYL SALICYLATE EXHIBITING ANTICOAGULATION ACTIVITY | 2019 |
|
RU2703513C1 |
TRIAZOLE DERIVATIVES EXHIBITING ANTIAGGREGATORY ACTIVITY | 2021 |
|
RU2770405C1 |
CYCLOHEXYLAMMONIUM SALT OF [3-METHYL-1-N-PROPYL-7-(1-OXOTHIETANYL-3)XANTHINYL-8-THIO]ACETIC ACID EXHIBITING ANTITHROMBOTIC ACTIVITY | 2011 |
|
RU2459826C1 |
AGENT WITH ANTIAGGREGATORY ACTIVITY AND METHOD FOR PRODUCTION THEREOF | 2021 |
|
RU2778686C1 |
ANTIAGGREGANT AND ANTIOXIDANT AGENT | 2023 |
|
RU2808474C1 |
SALTS OF [3-METHYL-1-N-PROPYL-7-(1,1-DIOXOTHIETANYL-3)XANTHINYL-8-THIO]ACETIC ACID, EXHIBITING PROAGGREGANT ACTIVITY | 2011 |
|
RU2459825C1 |
USE OF 5,7-DIHYDROXY-6,8-DIMETHYLFLAVANONE AS ANTI-AGGREGATION ACTIVITY | 2023 |
|
RU2812630C1 |
METHOD OF PRODUCING ANTIAGGREGATORY AND ANTIOXIDANT AGENT | 2023 |
|
RU2819387C1 |
HYDROCHLORIDES OF 1-ALKYL-3-METHYL-8-PIPERAZINO-7-(TIETHANYL-3)XANTHINE SHOWING ANTITHROMBOTIC EFFECT BY BLOCKING GP IIb-IIIa PLATELETS RECEPTORS | 2017 |
|
RU2640579C1 |
Authors
Dates
2020-07-22—Published
2019-02-18—Filed